Business Wire

1204 Articles

Analytical market data services, DeFi, and Index Management: dxFeed followed industry trends to reach 45% revenue increase

Aligning with the leading market data industry trends in analytical financial services,

Business Wire Business Wire

India Globalization Capital Appoints Former Congressman Jim Moran to Its Board of Directors

POTOMAC, Md.--(BUSINESS WIRE)--#IGC--India Globalization Capital, Inc. (NYSE American: IGC) is excited to

Business Wire Business Wire

ALAViDA Partners with Green Shield Canada to Meet the Rapidly Growing Demand for Virtual Substance Use Management

Partnership helps fill a critical and costly gap in employee mental health

Business Wire Business Wire

ALAViDA Partners with Green Shield Canada to Meet the Rapidly Growing Demand for Virtual Substance Use Management

Partnership helps fill a critical and costly gap in employee mental health

Business Wire Business Wire

Resonate Blends Announces “Love” Blend for Valentine’s Day Launch

Koan Cordials Expand to Seven Unique and Targeted Experiences CALABASAS, Calif.--(BUSINESS WIRE)--$KOAN

Business Wire Business Wire

Resonate Blends Announces “Love” Blend for Valentine’s Day Launch

Koan Cordials Expand to Seven Unique and Targeted Experiences CALABASAS, Calif.--(BUSINESS WIRE)--$KOAN

Business Wire Business Wire

Cresco Labs Announces Termination of Blair Wellness Acquisition

CHICAGO--(BUSINESS WIRE)--Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco Labs” or “the Company”), a vertically

Business Wire Business Wire

PTSD Patients in TXOG Focus Group Unanimously Report Symptom Relief Through Medical Cannabis

Texas Original Compassionate Cultivation assembled a focus group of veterans suffering from

Business Wire Business Wire

Virpax® Successfully Completes Preclinical Dermal Safety Studies for Epoladerm™

Well-tolerated with No Serious Adverse Findings BERWYN, Pa.--(BUSINESS WIRE)--#pharma--Virpax® Pharmaceuticals, Inc. (“Virpax”

Business Wire Business Wire

Applied DNA Announces Continued Momentum in COVID-19 Testing Demand

- FQ1’22 Testing Levels Up Over 90% Compared to FQ4’21, Reports Further

Business Wire Business Wire